MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge

Numerous vaccine candidates against SARS-CoV-2, the causative agent of the COVID-19 pandemic, are under development. The majority of vaccine candidates to date are designed to induce immune responses against the viral spike (S) protein, although different forms of S antigen have been incorporated. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Meseda, Clement A., Stauft, Charles B., Selvaraj, Prabhuanand, Lien, Christopher Z., Pedro, Cyntia, Nuñez, Ivette A., Woerner, Amy M., Wang, Tony T., Weir, Jerry P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642471/
https://www.ncbi.nlm.nih.gov/pubmed/34862398
http://dx.doi.org/10.1038/s41541-021-00410-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642471/
https://www.ncbi.nlm.nih.gov/pubmed/34862398
http://dx.doi.org/10.1038/s41541-021-00410-8

Ejemplares similares